CTXR logo

Citius Pharmaceuticals (CTXR) Accounts Payable

Annual Accounts Payable

$2.93 M
+$1.76 M+151.18%

30 September 2023

CTXR Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Payable

$1.66 M
-$1.01 M-37.69%

30 June 2024

CTXR Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CTXR Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--43.2%
3 y3 years+129.2%+30.2%
5 y5 years+7.9%-38.7%

CTXR Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+151.2%-46.0%+42.7%
5 y5 yearsat high+151.2%-46.0%+69.0%
alltimeall timeat high-46.0%

Citius Pharmaceuticals Accounts Payable History

DateAnnualQuarterly
June 2024
-
$1.66 M(-37.7%)
Mar 2024
-
$2.67 M(+0.8%)
Dec 2023
-
$2.65 M(-9.6%)
Sept 2023
$2.93 M(+151.2%)
$2.93 M(-4.9%)
June 2023
-
$3.08 M(+13.0%)
Mar 2023
-
$2.73 M(+77.3%)
Dec 2022
-
$1.54 M(+31.9%)
Sept 2022
-
$1.17 M(-31.1%)
Sept 2022
$1.17 M(-8.7%)
-
June 2022
-
$1.69 M(-0.9%)
Mar 2022
-
$1.71 M(-4.7%)
Dec 2021
-
$1.79 M(+40.1%)
Sept 2021
$1.28 M(-31.2%)
$1.28 M(-5.7%)
June 2021
-
$1.35 M(+19.6%)
Mar 2021
-
$1.13 M(+15.1%)
Dec 2020
-
$984.20 K(-47.0%)
Sept 2020
$1.86 M(-31.6%)
$1.86 M(+2.5%)
June 2020
-
$1.81 M(+18.8%)
Mar 2020
-
$1.52 M(-1.5%)
Dec 2019
-
$1.55 M(-43.0%)
Sept 2019
$2.71 M(+72.5%)
$2.71 M(+11.6%)
June 2019
-
$2.43 M(+26.2%)
Mar 2019
-
$1.93 M(-7.6%)
Dec 2018
-
$2.08 M(+32.4%)
Sept 2018
$1.57 M
$1.57 M(+72.5%)
June 2018
-
$912.30 K(-34.9%)
Mar 2018
-
$1.40 M(+149.6%)
DateAnnualQuarterly
Dec 2017
-
$561.20 K(-6.8%)
Sept 2017
$602.40 K(-33.7%)
$602.40 K(-69.5%)
June 2017
-
$1.98 M(+6.2%)
Mar 2017
-
$1.86 M(+89.0%)
Dec 2016
-
$985.90 K(+8.4%)
Sept 2016
$909.20 K(+62.6%)
$909.20 K(+194.0%)
June 2016
-
$309.20 K(-15.7%)
Mar 2016
-
$366.70 K(-20.1%)
Dec 2015
-
$458.70 K(-18.0%)
Sept 2015
$559.20 K(+426.6%)
$559.20 K(+67.3%)
June 2015
-
$334.30 K(-2.6%)
Mar 2015
-
$343.40 K(+72.5%)
Dec 2014
-
$199.10 K(+87.5%)
Sept 2014
$106.20 K(+823.5%)
$106.20 K(+6980.0%)
June 2014
-
$1500.00(+200.0%)
Mar 2014
-
$500.00(+150.0%)
Dec 2013
-
$200.00(-98.3%)
Sept 2013
$11.50 K(>+9900.0%)
$11.50 K(+2775.0%)
June 2013
-
$400.00(+100.0%)
Mar 2013
-
$200.00(-66.7%)
Dec 2012
-
$600.00(>+9900.0%)
Sept 2012
$0.00(-100.0%)
$0.00(-100.0%)
June 2012
-
$900.00(0.0%)
Mar 2012
-
$900.00(0.0%)
Dec 2011
-
$900.00(0.0%)
Sept 2011
$900.00
$900.00(0.0%)
June 2011
-
$900.00

FAQ

  • What is Citius Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Citius Pharmaceuticals?
  • What is Citius Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Citius Pharmaceuticals?
  • What is Citius Pharmaceuticals quarterly accounts payable year-on-year change?

What is Citius Pharmaceuticals annual accounts payable?

The current annual accounts payable of CTXR is $2.93 M

What is the all time high annual accounts payable for Citius Pharmaceuticals?

Citius Pharmaceuticals all-time high annual accounts payable is $2.93 M

What is Citius Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of CTXR is $1.66 M

What is the all time high quarterly accounts payable for Citius Pharmaceuticals?

Citius Pharmaceuticals all-time high quarterly accounts payable is $3.08 M

What is Citius Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, CTXR quarterly accounts payable has changed by -$1.26 M (-43.18%)